Chronic regulation of the expression of gap junction proteins connexin40, connexin43, and connexin45 in neonatal rat cardiomyocytes

European Journal of Pharmacology

Volumn 503, Issue 1-3, 2004, Pages 9-16

  Salameh, Aida ^a,b   Schneider, Polin ^a   Mühlberg, Katja ^a   Hagendorff, Andreas ^a   Dhein, Stefan ^b   Pfeiffer, Dietrich ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cardiomyocyte, rat; Connexin; Gap junction; MAP kinase; TNF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 IMIDAZOLECARBOXYLIC ACID ETHYL ESTER; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; GAP JUNCTION PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE CELL; IMMUNOHISTOLOGY; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 7444225800     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.024     Document Type: Article

References (40)

1. D.R. Alessi, A. Cuenda, P. Cohen, D.T. Dudley, and A.R. Saltiel PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo J. Biol. Chem. 270 1995 27489 27494
2. B. Arensbak, H.B. Mikkelsen, F. Gustafsson, T. Christensen, and N.H. Holstein-Rathlou Expression of connexin 34, 40 and 43 mRNA and protein in renal glomerular arterioles Histochem. Cell Biol. 115 2001 479 487
3. R. Bruzzone, T.W. White, and D.L. Paul Connections with connexins: the molecular basis of direct intercellular signalling Eur. J. Biochem. 238 1996 1 27
4. E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, and J.T. Willerson Anti-TNF therapy against congestive heart failure investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial Circulation 107 25 2003 3133 3140
5. B.J. Darrow, J.G. Laing, P.D. Lampe, J.E. Saffitz, and E.C. Beyer Expression of multiple connexins in cultures neonatal rat ventricular myocytes Circ. Res. 76 1995 381 387
6. B.J. Darrow, V.G. Fast, A.G. Kléber, E.C. Beyer, and J.E. Saffitz Functional and structural assessment on intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes Circ. Res. 79 1996 174 183
7. S.P. Davies, H. Reddy, M. Caivano, and P. Cohen Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem. J. 351 2000 95 105
8. S. Dhein Gap junction channels in the cardiovascular system: pharmacological and physiological modulation Trends Pharmacol. Sci. 19 1998 229 241
9. S. Dhein Cardiac gap junction Physiology, Regulation, Pathophysiology and Pharmacology 1998 Karger Verlag Basel 110 114
10. E. Dupont, T. Matsushita, R.A. Kaba, C. Vozzi, S.R. Coppen, N. Khan, R. Kaprielian, M.H. Yacoub, and N.J. Severs Altered connexin expression in human congestive heart failure J. Mol. Cell. Cardiol. 33 2001 359 371
11. J. Eder Tumor necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol. Sci. 18 1997 319 322
12. J.M. English, and M.H. Cobb Pharmacological inhibitors of MAPK pathways Trends Pharmacol. Sci. 23 2002 40 45
13. E.A. Eugenin, D. Eckardt, M. Theis, K. Willecke, M.V. Bennett, and J.C. Saez Microglia at brain stab wounds express connexin43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha Proc. Natl. Acad. Sci. U. S. A. 98 2001 4190 4195
14. M. Fernandez-Cobo, C. Gingalewski, D. Drujan, and A. DeMaio Expression of the connexin 43 gene is increased in the kidneys and lungs of rats injected with bacterial lipopolysaccharide Shock 10 2 1998 97 102
15. M. Fernandez-Cobo, C. Gingalewski, D. Drujan, and A. DeMaio Downregulation of connexin43 gene expression in rat heart during inflammation. The role of tumor necrosis factor Cytokine 11 1999 216 224
16. G.Z. Feuerstein, and P.R. Young Apoptosis in cardiac disease: stress- and mitogen-activated signalling pathways Cardiovasc. Res. 45 3 2000 560 569
17. J.B.C. Findlay Purification of membrane proteins E.L.V. Harris S. Angal Protein Purification Applications 1990 IRL Oxford, UK 59 82
18. M. Goedert, A. Cuenda, M. Craxton, R. Jakes, and P. Cohen Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases EMBO J. 16 1997 3563 3571
19. H.E. González, E.A. Eugenín, G. Garcés, N. Solis, M. Pizarro, L. Accatino, and J.C. Saez Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory mediators Am. J. Physiol.: Gasterointest. Liver Physiol. 282 2002 G991 G1001
20. G.E. Grau, T.E. Taylor, M.E. Molyneux, J.J. Wirima, P. Vassalli, M. Hommel, and P.H. Lambert Tumor necrosis factor and disease severity in children with falciparum malaria N. Engl. J. Med. 320 24 1989 1586 1591
21. D.B. Gros, and H.J. Jongsma Connexins in mammalian heart function BioEssays 18 1996 719 730
22. H. He, H.L. Li, A. Lin, and R.A. Gottlieb Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia Cell Death Differ. 6 10 1999 987 991
23. H.L. Kanter, J.G. Laing, S.L. Beau, E.C. Beyer, and J.E. Saffitz Distinct patterns of connexin expressions in canine purkinje fibres and ventricular muscle Circ. Res. 72 1993 1124 1131
24. H.L. Kanter, J.G. Laing, E.C. Beyer, K.G. Green, and J.E. Saffitz Multiple connexins colocalise in canine ventricular myocyte gap junctions Circ. Res. 73 1993 344 350
25. R.R. Kaprielian, M. Gunning, E. Dupont, M.N. Sheppard, S.M. Rothery, R. Underwood, D.J. Pennell, K. Fox, J. Pepper, P.A. Poole-Wilson, and N.J. Severs Downregulation of immunodetectable connexin 43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle Circulation 97 1998 651 660
26. J.B. Klein, G.W. Wang, Z. Zhou, A. Buridi, and Y.J. Kang Inhibition of tumor necrosis factor-alpha-dependent cardiomyocyte apoptosis by metallothionein Cardiovasc. Toxicol. 2 3 2002 209 218
27. D. Kwiatkowski, A.V.S. Hill, I. Sambou, P. Twumasi, J. Castracane, K.R. Manogue, A. Cerami, D.R. Brewster, and B.M. Greenwood TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated plasmodium falciparum malaria Lancet 336 1990 1201 1204
28. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, W.S. Colucci, J. Djian, H. Drexler, A. Feldmann, L. Kober, L. Krum, P. Liu, M. Nieminen, L. Tavazzi, D.J. van Veldhuisen, A. Waldenstrom, M. Warren, A. Westheim, F. Zannad, and T. Fleming Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENUAL) Circulation 109 13 2004 1594 1602
30. M.M. McLaughlin, S. Kumar, P.C. McDonnell, S. Van Horn, J.C. Lee, G.P. Livi, and P.R. Young Identification of mitogen-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase J. Biol. Chem. 271 1996 8488 8492
31. D.R. Meldrum Tumor necrosis factor in the heart Am. J. Physiol. 274 1998 R577 R595
32. D. Perkins, J. Weinberg, and P. Kremsner Reduced interleukin-12 and transforming growth factor b1 in severe childhood malaria: relationship of cytokine balance with disease severity J. Infect. Dis. 182 2000 988 992
33. R.C. Pimentel, K.A. Yamada, A.G. Kléber, and J.E. Saffitz Autocrine regulation of myocyte Cx43 expression by VEGF Circ. Res. 90 2002 671 677
34. L. Polontchouk, B. Ebelt, M. Jackels, and S. Dhein Chronic effects of endothelin-1 and angiotensin-II on gap junctions and intercellular communication in cardiac cells FASEB J. 15 2001 U188 U202
35. L. Polontchouk, J.-A. Haefliger, B. Ebelt, T. Schaefer, D. Stuhlmann, U. Mehlhorn, F. Kuhn-Regnier, E.R. DeVivie, and S. Dhein Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria J. Am. Coll. Cardiol. 38 2001 883 891
36. A. Salameh, L. Polontchouk, S. Dhein, A. Hagendorff, and D. Pfeiffer Chronic regulation of the expression of the gap junction protein connexin 43 in transfected HeLa cells Naunyn-Schmiedeberg's Arch. Pharmacol. 368 2003 33 40
37. A. Temme, O. Traub, and K. Willecke Downregulation of connexine32 protein and gap-junctional intercellular communication by cytokine-mediated acute-phase response in immortalised mouse hepatocytes Cell Tissue Res. 294 1998 345 350
38. H.V. Van Rijen, M.V. Van Kempen, S. Postma, and H.J. Jongsma Tumor necrosis factor alpha alters the expression of connexin43, connexin40 and connexin37 in human umbilical vein endothelial cells Cytokine 10 1998 258 264
39. S. Verheule, M.J.A. Van Kempen, P.H.J.A. Te Welscher, B.R. Kwak, and H.H. Jongsma Characterisation of gap junction channels in adult rabbit atrial and ventricular myocardium Circ. Res. 80 1997 673 681
40. S. Von Haehling, E.A. Jankowska, and S.D. Anker Tumor necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications Basic Res. Cardiol. 99 1 2004 18 28